Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (311-320 of 975) with videos related to

Pageof 98
Sort By:
Anticancer Research|September 10, 2014
HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesionsGrit Mehlhorn, Simone K Hautmann, Martin C Koch, et al.
Molecular Cancer Research : MCR|December 17, 2013
Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencingMartin Hart, Elke Nolte, Sven Wach, et al.
Melanoma Research|June 13, 2014
Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanomaEkaterina Pisareva, Nadezhda Gutkina, Sergei Kovalenko, et al.
BMC Cancer|February 12, 2013
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapyBastian Keck, Sven Wach, Robert Stoehr, et al.
The Journal of Urology|April 18, 2007
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosisSusan Cottrell, Klaus Jung, Glen Kristiansen, et al.
The Journal of Urology|May 16, 2006
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJames W F Catto, Arndt Hartmann, Robert Stoehr, et al.
The American Journal of Surgical Pathology|April 13, 2018
NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland CarcinomasAbbas Agaimy, Isabel Fonseca, Carmo Martins, et al.
Virchows Archiv : an International Journal of Pathology|October 22, 2008
Immunophenotyping and oncogene amplifications in tumors of the papilla of VaterDaniel Baumhoer, Inti Zlobec, Luigi Tornillo, et al.
Histopathology|January 4, 2012
Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic valueDavid L Wachter, Glen Kristiansen, Christopher Soll, et al.
Histopathology|August 22, 2024
TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscapeAbbas Agaimy, Andres M Acosta, Liang Cheng, et al.
Pageof 98

Showing results (311-320 of 975) with videos related to

Sort By:
Pageof 98
Anticancer Research|September 10, 2014
HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesionsGrit Mehlhorn, Simone K Hautmann, Martin C Koch, et al.
Molecular Cancer Research : MCR|December 17, 2013
Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencingMartin Hart, Elke Nolte, Sven Wach, et al.
Melanoma Research|June 13, 2014
Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanomaEkaterina Pisareva, Nadezhda Gutkina, Sergei Kovalenko, et al.
BMC Cancer|February 12, 2013
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapyBastian Keck, Sven Wach, Robert Stoehr, et al.
The Journal of Urology|April 18, 2007
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosisSusan Cottrell, Klaus Jung, Glen Kristiansen, et al.
The Journal of Urology|May 16, 2006
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJames W F Catto, Arndt Hartmann, Robert Stoehr, et al.
The American Journal of Surgical Pathology|April 13, 2018
NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland CarcinomasAbbas Agaimy, Isabel Fonseca, Carmo Martins, et al.
Virchows Archiv : an International Journal of Pathology|October 22, 2008
Immunophenotyping and oncogene amplifications in tumors of the papilla of VaterDaniel Baumhoer, Inti Zlobec, Luigi Tornillo, et al.
Histopathology|January 4, 2012
Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic valueDavid L Wachter, Glen Kristiansen, Christopher Soll, et al.
Histopathology|August 22, 2024
TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscapeAbbas Agaimy, Andres M Acosta, Liang Cheng, et al.
Pageof 98